Licensing the Technology: Biotechnology Commercialization Strategies Using University and Federal Labs
Steven M. Ferguson and Uma S. Kaundinya
In: Craig Shimasaki, ed. Biotechnology Entrepreneurship: Starting, Managing, and Leading Biotech Companies. (Elsevier Inc.) 2014:185-206. |
|
Research Discoveries after Kubin
Nancy W. Vensko and Steven M. Ferguson
In: AUTM Technology Transfer Practices Manual, Vol 4, Part I. 3rd ed.; 2010:1-20. |
|
Research Tools Policies and Practices: Perspective of a Public Institution
Uri Reichman, Susan E. Ano, and Steven M. Ferguson
In: AUTM Technology Transfer Practices Manual, Vol 4. 3rd ed.; 2010:1-29. |
|
Licensing and Technology Transfer
Steven M. Ferguson and Ruchika Nijhara
In: ML Salgaller, ed. Biotechnology Entrepreneurship - From Science to Solutions. (Washington DC: Logos Press) 2010:113-132. |
|
Partnerships for Global Vaccine Development - Rotavirus Vaccine and Partnerships for Global Vaccine Development - Meningitis Vaccine Project (MVP) for Sub Saharan Africa
Kevin Chang, Peter Soukas, Susan Ano, and Uri Reichman
Poster presented at: Clinical and Translational Science Award (CTSA) Industry Forum; February 2010; Bethesda, MD |
|
Research Discoveries after Kubin
Nancy W. Vensko and Steven M. Ferguson
Tomorrow's Technology Transfer. 2010 Winter/Spring;2(1):46-58. |
|
Commercial Licensing of HIV-1 Protease: Applications of the NIH Research Tools Policy
George H. Keller and Steven M. Ferguson
J Biolaw Bus. 2009;12(4):1-5. |
|
Technology Transfer at the National Institutes of Health
Mark L. Rohrbaugh and Brian R. Stanton
In: P Ganguli, R Khanna, B Prickril, eds. Technology Transfer in Biotechnology: A Global Perspective. (Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA) 2009:38-58. |
|
Intellectual Property and Other Contractual Issues in Cooperative Research and Development Agreements (CRADAs): Part II
Matthew W. Sagal, Gene Slowinski, Kenneth Freese, and Steven Ferguson
les Nouvelles. 2009 Jun;44(2):79-86. |
|
Intellectual Property and Other Contractual Issues in Cooperative Research and Development Agreements (CRADAs): Part I
Matthew W. Sagal, Gene Slowinski, Kenneth Freese, and Steven Ferguson
les Nouvelles. 2009 Mar 1;44(1):41-48. |
|
Transfer and Valuation of Biomedical Intellectual Property
Cristina Thalhammer-Reyero
In: J Horvath and D Chodikoff, eds. Taxation and Valuation of Technology: Theory, Practice, and the Law. (Toronto, Canada: Irwin Law Inc.) 2008:603-641. |
|
NIH Offers Licensing Agreements to Commercialize Technologies
Mark L. Rohrbaugh
BioPharm International. 2008 Mar 1;20(3):60-66. |
|
Biopharmaceutical Research Collaborations between India and the West: A Guide to Prospective Partnerships
Uri Reichman, Bharat Khurana, and Steven M. Ferguson
In: ES Langer, ed. Advances in Biopharmaceutical Technology in India. (BioPlan Associates, Inc.: Rockville MD and Society for Industrial Microbiology: Arlington VA) 2008:661-722. |
|
Typhoid Vaccine: NIH Office of Technology Transfer and the International Vaccine Institute
Peter Soukas and Uri Reichman
In: A Krattiger, RT Mahoney, L Nelson, et al, eds. Executive Guide to Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices. (MIHR: Oxford, UK and PIPRA: Davis, CA) 2007:CS32-CS33. |
|
Rotavirus Vaccine: NIH Office of Technology Transfer
Uri Reichman
In: A Krattiger, RT Mahoney, L Nelson, et al, eds. Executive Guide to Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices. (MIHR: Oxford, UK and PIPRA: Davis, CA) 2007:CS30-CS31. |
|
Administration of Technology Licenses
Hans H. Feindt
In: A Krattiger, RT Mahoney, L Nelson, et al, eds. Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices. (MIHR: Oxford, UK and PIPRA: Davis, CA) 2007:1395-1403. |
|
Technology Transfer
Jack Spiegel
In: JI Gallin, FP Ognibene, eds. Principles and Practice of Clinical Research. 2nd ed. (Elsevier Inc.) 2007;315-344. |
|
Knowledge and Technology Mobilization to Advance Public Health: An NIH Perspective
Jack Spiegel
In: Y Blais, ed. Intellectual Property at the Edge: New Approaches to IP in a Transsystemic World – MEREDITH Lectures 2006 (Thomson Reuters Canada) 2007. |
|
Partnerships for Innovation and Global Health: NIH International Technology Transfer Activities
Mark L. Rohrbaugh
In: A. Krattinger et al., ed Intellectual Property Management in Health and Agricultural Innovation, 2007:1709-1718 |
|
Biopharmaceutical Research Collaboration between Western and Chinese Life Science Organizations: A Guide to Prospective Partnerships
Steven M. Ferguson, Sally H. Hu, and Uri Reichman
In: ES Langer, ed. Advances in Biopharmaceutical Technology in China. (BioPlan Associates, Inc.: Rockville MD and Society for Industrial Microbiology: Fairfax VA) 2006:935-1017. |
|
Avoiding the Avalanche: Records Management Techniques for Improving Workflow in Technology Transfer Offices
David R. Sadowski
In: AUTM Technology Transfer Practice Manual, Vol 2, Part 1, 3rd ed. Chapter 8.3; 2006. |
|
Beyond Patents and Royalties: the Perception and Reality of Doing Business with the NIH
Gil Ben-Menachem, Steven M. Ferguson, and Krishna Balakrishnan
Nat Biotechnol. 2006 Jan;24(1):17-20. |
|
Partnerships in Technology Transfer: An Innovative Program to Move Biomedical and Health Technologies from the Laboratory to Worldwide Application
Luis A Salicrup, Rachelle F. Harris, and Mark L Rohrbaugh
IP Strategy. 2005; No. 12-2005, pp. 1-12. |
|
Nature's Medicines: Traditional Knowledge and Intellectual Property Management. Case Studies from the National Institutes of Health (NIH), USA
Ranjan Gupta, Bjarne Gabrielsen, and Steven M. Ferguson
Curr Drug Discov Technol. 2005 Dec;2(4):203-19. |
|
Effective Strategies for Marketing Biomedical Inventions: Lessons Learnt from NIH Licence Leads
Vivek Ramakrishnan, Jiwen Chen, and Krishna Balakrishnan
Journal of Medical Marketing. 2005 Nov;5(4):342-52. |
|
Bypassing Bypass Surgery and Other Success Stories from the National Institutes of Health
Ruchika Nijhara, J. Lille Tidwell, Steven M. Ferguson, and Krishna Balakrishnan
AUTM Journal. 2005 Fall:17(2):1-16. |
|
Technology Marketing — Strategies and Tools That Work
Catherine E. Vorwald, Sigrid M. Volko, and Steven M. Ferguson
Presented at: Licensing Executives Society Annual Meeting; October 2005; Phoenix AZ. |
|
Technology Transfer & Disruptive Innovation at NIH: The Case of Taxus Express™
Steven M. Ferguson
Presented at: Technology Transfer Society Annual Meeting; September 2005; Kansas City MO. |
|
Developing Products for Personalized Medicine: NIH Research Tools Policy Applications
Steven M. Ferguson
Presented at: IBC's 4th Annual Conference on Molecular Diagnostics and Personalized Medicine; September 2005; Boston MA. |
|
Distribution of Data and Unique Material Resources Made with NIH Funding
Mark L. Rohrbaugh
J. Commercial Biotech; 2005;11(3):249-262 |
|
Partnerships in Technology Transfer. An Innovative Program to Enhance Biomedical Research and Global Health (Editorial)
Mark L. Rohrbaugh and L.A. Salicrup
Int'l Microbiology; 2005;8:1-3 |
|
Developing Products for Personalized Medicine: NIH Research Tool Policy Applications
Ranjan Gupta, JP Kim, Jack Spiegel, and Steven M. Ferguson
Personalized Medicine. 2004;1(1):115-24. |
|
Intellectual Property
Mark L. Rohrbaugh
In: M. Rao and A. Chiu ed. Human Embryonic Stem Cells and Other Pluripotent Cells (Humana Press) 2003 |
|
Monitoring of Biomedical License Agreements — A Practical Guide
George H. Keller, Steven M. Ferguson, and Percy Pan
Pharm Dev Regul. 2003 Jan 1;1(3):191-203. |
|
Distribution and Licensing of Drug Discovery Tools — NIH Perspectives
Steven M. Ferguson and JP Kim
Drug Discovery Today. 2002 Nov;7(21):1102-6. |
|
Developing New Products from NIH Research — Technology Transfer "Supermarkets" and "White Knights"
Steven M. Ferguson
Clin Eval. 2002;29(2-3):295-301. (Japanese) |
|
Products, Partners & Public Health: Transfer of Biomedical Technologies from the U.S. Government
Steven M. Ferguson
J Biolaw Bus. 2002;5(2):35-9. |
|
Licensing and Distribution of Research Tools: National Institutes of Health Perspective
Steven M. Ferguson
J Clin Pharmacol. 2001 Jul;41(Supplement):110S-12S. |
|